Uncommon Concurrent Retinal and Cerebral Metastasis in High-risk Neuroblastoma: Diagnostic Utility of 68Ga-DOTATATE PET/CT Despite Negative 18F-FDG PET/CT.

Clin Nucl MedAug 14, 2026 (epub)

Siqi Li, Meng Liu, Bingyan Zhang et al.

✦ AI-curated · Sources linked

Case in brief

A 5-year-old girl with high-risk neuroblastoma presented for surveillance with an 18F-FDG PET/CT, which showed two metabolically silent lesions in the right retina and brain. A subsequent 68Ga-DOTATATE PET/CT revealed significant radiotracer uptake in both lesions, indicating somatostatin receptor expression. Despite diagnosis, the patient experienced progressive disease and passed away two months later.

What made this case unusual

The case highlights the diagnostic utility of 68Ga-DOTATATE PET/CT in identifying lesions that were not visible on 18F-FDG PET/CT, demonstrating a unique imaging characteristic in neuroblastoma metastasis.

Diagnostic / clinical pearl

Clinicians should consider 68Ga-DOTATATE PET/CT for detecting neuroblastoma metastases, especially when 18F-FDG PET/CT results are inconclusive.

Why it matters

This case underscores the importance of using multiple imaging modalities to improve diagnostic accuracy in high-risk neuroblastoma patients.

Source

Published in Clin Nucl Med. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.